Clinical Trials
3
Active:0
Completed:3
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)Study of AggreGuide A-100 (ADP) Assay
Not Applicable
Completed
- Conditions
- Platelet Dysfunction Due to DrugsRisk Factor, Cardiovascular
- Interventions
- Drug: P2Y12 inhibitorDevice: Platelet function test
- First Posted Date
- 2017-04-12
- Last Posted Date
- 2019-02-21
- Lead Sponsor
- Aggredyne, Inc.
- Target Recruit Count
- 280
- Registration Number
- NCT03111420
Aggreguide A-100 ADP Assay Evaluation
Completed
- Conditions
- ADP BlockersPlatelet Aggregation
- First Posted Date
- 2014-04-14
- Last Posted Date
- 2017-04-04
- Lead Sponsor
- Aggredyne, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT02112539
- Locations
- 🇺🇸
Juno Research, Houston, Texas, United States
AggreGuide 325 mg. Aspirin Study for Aspirin Induced Platelet Dysfunction
Completed
- Conditions
- Platelet Dysfunction Due to Aspirin Ingestion
- First Posted Date
- 2013-08-02
- Last Posted Date
- 2013-08-02
- Lead Sponsor
- Aggredyne, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT01915407
- Locations
- 🇺🇸
Aggredyne, Inc., Houston, Texas, United States
News
No news found